Retail pharmacies up consumer satisfaction

Share this article:
Retail pharmacies are on the rebound
Retail pharmacies are on the rebound

Pharmacy benefits managers like CVS Caremark and Express Scripts compile reams of data about patients' medication adherence habits and refill trends. This data is particularly helpful for employers and payers seeking to lower healthcare costs, with one idea being, more medications on hand results in stronger regimens. The carrot in this scenario is often mail-order pharmacy fills, offering patients a lower overall cost for a prescription fill that lasts a longer amount of time than one that can be typically be picked up at a retail counter.

Yet a study by JD Power indicates that mail order's edge appears to have plateaued and the shift can be seen in refills: 74% of polled consumers used mail-order for refills in 2012 and 2013 -- what JD Power's director of healthcare Scott Hawkins calls mail-order's bread and butter -- while 61% of polled consumers said they used retail pharmacies for refills compared with 58% three years ago.

Retail pharmacies have been on a tear of late, increasing patient services to offer an increasing array of vaccinations, physical exams, as well as offering diagnoses of conditions like diabetes and high cholesterol.

Hawkins said retail has some up-front options for improving the consumer experience and has been adept at meeting the customer. “They can make the counter location more convenient. They can add drive-up windows,” he said.

Hawkins did not have any retail-adherence data to share, but said that the inversion of satisfaction ratings is significant for the mail-order channel, which has to provide high-touch and consumer convenience.

But notes that this does not mean mail order does not have the same opportunity to better connect with consumers, despite fewer touchpoints. Instead, he says mail order needs to get more creative about using channels like phone, internet and other forms of outreach to create a better service profile. This is not just about pretty sites or well-written texts, however. Hawkins notes that mail order has to contend with a mindset that can accompany what payers consider a mail-order incentive. “If somebody is compelled to use mail order, their satisfaction is much lower,” he says.

Share this article:
You must be a registered member of MMM to post a comment.

Next Article in Channel

Email Newsletters

MM&M Future Leaders

Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 


Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...